Levapharm Injection 75 mg/ml
Levapharm Injection 75 mg/ml
Authorised
- Levamisole hydrochloride
Product identification
Medicine name:
Levapharm Injection 75 mg/ml
Active substance:
- Levamisole hydrochloride
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Levamisole hydrochloride88.39/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal14day
-
-
Sheep
-
Meat and offal14day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- The veterinary medicinal product is supplied in glass vials in a cardboard box, sealed with bromobutyl bung and aluminium seals. Package size: 1 x 100 ml vial in a cardboard box
- The veterinary medicinal product is supplied in glass vials in a cardboard box, sealed with bromobutyl bung and aluminium seals. Package size: 1 x 250 ml vial in a cardboard box
- The veterinary medicinal product is supplied in glass vials in a cardboard box, sealed with bromobutyl bung and aluminium seals. Package size: 1 x 500 ml vial in a cardboard box
- The veterinary medicinal product is supplied in glass vials in a cardboard box, sealed with bromobutyl bung and aluminium seals. Package size: 6 x 500 ml vials with 1 protective container in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chem-Pharm (Ballyvaughan) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10823/010/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 7/06/2026